Malaysian Genomics Resource Centre Berhad (KLSE:MGRC)

Market Cap	27.44M
Revenue (ttm)	5.10M
Net Income (ttm)	-3.53M
Shares Out	137.21M
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,100
Average Volume	58,705
Open	0.2200
Previous Close	0.2200
Day's Range	0.2200 - 0.2200
52-Week Range	0.1450 - 0.4200
Beta	0.71
RSI	40.91
Earnings Date	Aug 20, 2025

About KLSE:MGRC

Malaysian Genomics Resource Centre Berhad, together with its subsidiaries, provides genetics, genomics, immunotherapy, and biopharmaceutical services worldwide. Its flagship product, Dtect genetic screening tests, inspects DNA for markers associated with genetic variations that influence various biological processes. The company offers genome sequencing services for humans, animals, and microbes and other living organisms; transcriptome sequencing; and metagenomics and metatranscriptomics. It also offers genome analysis services, including bioi...

• Industry: Commercial Physical and Biological Research
• Founded: 2004
• Employees: 16
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: MGRC

Financial Performance

In 2024, KLSE:MGRC's revenue was 5.52 million, a decrease of -42.32% compared to the previous year's 9.57 million. Losses were -4.19 million, -78.00% less than in 2023.